TP53 and neoplasm: The laboratory of P. G. Pellicci has recently demonstrated that targeted mutation of the tumor suppressor p53 in mammary stem cells increases the frequency of stem cell symmetric division thus increasing susceptibility to tumor development in the mammary gland [63].